Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2025 Earnings Call Transcript March 5, 2026 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.07.

FDA PMA establishes Claire as the first AI-integrated imaging device indicated for real-time intraoperative margin assessment during breast-conserving surgery. Re-excision remains ~20% nationally, ...

Aegon NV ADR (NYSE:AEG) presented its second half 2025 results on February 19, 2026, reporting strong financial performance across all key metrics, including a 15% year-over-year increase in operating ...

Air France-KLM (EURONEXT:AF) reported record financial results for fiscal year 2025, with operating profit breaking the €2 billion mark and operating margin improving to 6.1%, according to the company ...

Executive Summary Aegon reported operating capital generation of €1.3 billion for fiscal year 2025, exceeding its target of €1.2 billion. The company’s operating result grew to €1.7 billion, ...

Lisa Roath was appointed chief operating officer at Target Corp. From the Minneapolis/St. Paul Business Journal. Michael Fiddelke, the new CEO of Target Corp., is promoting two top managers as he ...

Greensburg, Pa.-based Independence Health System reported a combined operating loss of $7.4 million in the first half of fiscal 2026, an improvement from a $16.3 million loss during the same period ...

Hilton, N.Y. (WHAM) — Two months after a water leak forced the evacuation of 131 residents from Hilton East Assisted Living Facility in Hilton, the facility is House destroyed in second-alarm ...

The Lawrence school district offices building, located at 110 McDonald Dr., is pictured in May 2025. Lawrence school board members next week will take a first look at a policy setting a target range ...

Target is expanding, opening at least 30 new stores in over 20 states with dates yet to be released, according to the retailer's upcoming locations webpage. The dozens of locations listed on the site ...

The new price target reflects a higher revenue forecast, despite a recent spike in memory costs. Here are the details. Morgan Stanley raised its price target on Apple to $315.00 from $305.00 on ...